Tizanidine Tablet
Product Images NDC 60505-0252

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 60505-0252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1.jpg (Figure 1)

The text describes a figure showing the mean concentration of Tizanidine over time for tablets and capsules of 2 x 4 mg dosage under fasted and fed conditions.*

FDA Label Image

Figure-2.jpg (Figure 2)

The text describes a figure (Figure 2) that displays data from a single-dose study, showing the mean change in muscle tone from the baseline (as measured by the Ashworth Scale) over time (in hours post-dose). The scale is measured on a negative scale, where a lower score indicates an improvement in muscle tone from the baseline. The figure also includes a 95% confidence interval. No further information is available.*

FDA Label Image

Figure-3.jpg (Figure 3)

FDA Label Image

Chemical-structure (Tizanidine Imtb 01)

FDA Label Image

Tizanidine-label-2mg.jpg (Tizanidine Label 2mg)

These tablets contain 2 mg of tizanidine base equivalent to 2.268 mg of tizanidine hydrochloride. They should be stored between 20-25°C (68-77°F) with limited excursions from 15-30°C (59-86°F). They must be kept in a tight and light-resistant container. The usual dosage instructions are included in the package. These tablets should not be confused with tizanidine capsules or Zanaflex capsules and are a product of Apotex Corp.*

FDA Label Image

Tizanidine-label-4mg-150s.jpg (Tizanidine Label 4mg 150s)

This is a description of the medication Tizanidine. Each tablet contains 4 mg of Tizanidine hydrochloride, and they must be stored in a container at controlled room temperature. The usual dosage is specified on the package insert. It is a registered trademark of Acorda Therapeutics Inc. The medicine comes in a pack of 150 tablets made by Apotex Corp. The capsules are not interchangeable with that of Tizani capsules or Zanaflex capsules.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.